Guidelines for controlled trials of drugs in tension-type headache: Second edition

Cephalalgia

Volumn 30, Issue 1, 2010, Pages 1-16

  Bendtsen, L ^a   Bigal, M E ^a   Cerbo, R ^a   Diener, H C ^a   Holroyd, K ^a   Lampl, C ^a   Mitsikostas, D D ^a   Steiner, T J ^a   Tfelt Hansen, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute treatment; Clinical Trials; Prophylactic treatment; Tension type headache

Indexed keywords

ANALGESIC AGENT; PLACEBO;

ADVERSE OUTCOME; AREA UNDER THE CURVE; CHRONIC TENSION HEADACHE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG INTERACTION; DRUG USE; EPISODIC TENSION HEADACHE; EVALUATION AND FOLLOW UP; GENDER; HUMAN; LIVER TOXICITY; METHODOLOGY; MIGRAINE; NEPHROTOXICITY; ONSET AGE; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PATIENT MONITORING; PATIENT SELECTION; PLACEBO EFFECT; PRACTICE GUIDELINE; PREVALENCE; PROPHYLAXIS; PUBLICATION; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZATION; REVIEW; STATISTICAL ANALYSIS; STRATIFICATION; TENSION HEADACHE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TENSION-TYPE HEADACHE;

EID: 77951820673     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01948.x     Document Type: Review

References (66)

1. Schoenen J. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia 1995;15:165-79.
2. Tfelt-Hansen P. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia 1991;11:1-12.
3. Tfelt-Hansen P, Block G, Dahlof C, Diener HC, Ferrari MD, Goadsby PJ, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20:765-86.
4. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, et al. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008;28:484-95.
5. Lipton RB, Micieli G, Russell D, Solomon S, Tfelt-Hansen P, Waldenlind E. Guidelines for controlled trials of drugs in cluster headache. Cephalalgia 1995;15:452-62.
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl. 1):9-160.
7. Guiloff RJ. Clinical trials in neurology. London: Springer-Verlag London Ltd, 2001.
8. Spilker B. Guide to clinical trials. New York: Raven Press, 1991.
9. Meinert CL. Clinical trials-design, conduct, analysis. Oxford: Oxford University Press, 1986.
10. Pocock SJ. Clinical trials. A practical approach. Chichester: John Wiley & Sons, 1983.
11. Bendtsen L. Tension-type headache. In: Macgregor A, Jensen R (eds) Migraine and other primary headaches. Oxford: Oxford Pain Medicine Library, Oxford University Press, 2008, p. 103-12.
12. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol 2007;20:326-30.
13. Bendtsen L, Jensen R. Tension-type headache: the most common, but also the most neglected, headache disorder. Curr Opin Neurol 2006;19:305-9.
14. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen R, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 1992;12:369-74.
15. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000;20:603-10.
16. Mulleners WM, Whitmarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 1998;18:52-6.
17. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: a Danish epidemiologic follow-up study. Am J Epidemiol 2005;161:1066-73.
18. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005;20:243-9.
19. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;4:381-3.
20. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population-a prevalence study. J Clin Epidemiol 1991;44:1147-57.
21. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.
23. Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003;23:59-66.
24. Leber PD. Hazard of inference: the active control investigation. Epilepsia 1989;30(Suppl. 1):S57-63.
25. Bendtsen L. Methodological aspects of three-way crossover trials in tension-type headache. In: Olesen J, Tfelt-Hansen P (eds) Headache treatment. Trial methodology and new drugs. Philadelphia, PA: Lippincott-Raven, 1997, p. 51-3.
26. Bendtsen L. Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 2000;20:486-508.
27. Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 2005;25:776-87.
28. Laska EM, Siegel C, Sunshine A. Onset and duration: measurement and analysis. Clin Pharmacol Ther 1991;49:1-5.
29. Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003;7:155-62.
30. Steiner TJ, Lange R, Voelker M. Episodic tension-type headache (ETTH): evidence of prolonged disability from a placebo-controlled comparison of aspirin and paracetamol. Cephalalgia 2008;23:630.
31. Dixon JR Jr. The International Conference on Harmonization Good Clinical Practice guideline. Qual Assur 1998;6:65-74.
32. Bendtsen L, Buchgreitz L, Ashina S, Jensen R. Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. Eur J Neurol 2007;14:187-93.
33. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001;285:2208-15.
34. Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985;25:273-5.
35. Gobel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994;59:241-9.
36. Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994;14:149-55.
37. Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 1990;30:118-21.
38. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996;61:285-90.
39. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62:1706-11.
40. Zissis N, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K. Arandomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 2007;27:315-24.
41. Lampl C, Marecek S, May A, Bendtsen L. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tensiontype headache. Cephalalgia 2006;26:1203-8.
42. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache 1994;34:20-4.
43. Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F, et al. A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 1990;30:439-44.
44. Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 1994;34:44-9.
45. Bendtsen L, Mathew NT. Prophylactic pharmacotherapy of tension-type headache. In: Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KM (eds) The headaches, 3th edn. Philadelphia, PA: Lippincott Williams Wilkins, 2005, p. 735-41.
46. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open forabroader concept of chronic migraine. Cephalalgia 2006;26:742-6.
47. Lewis JA. Migraine trials: crossover or parallel group? Neuroepidemiology 1987;6:198-208.
48. Sorensen PS, Hansen K, Olesen J. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia 1986;6:7-14.
49. Olesen J, Tfelt-Hansen P. Headache. In: Porter RJ, Schoenberg BS (eds) Controlled clinical trials in neurological disease. London: Kluwer Academic, 1990, p. 185-201.
50. Olesen J, Krabbe AA, Tfelt-Hansen P. Methodological aspects of prophylactic drug trials in migraine. Cephalalgia 1981;1:127-41.
51. Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984;69:1-8.
52. Lake AE III, Saper JR. Chronic headache: new advances in treatment strategies. Neurology 2002;59: S8-13.
53. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006;66:1894-8.
54. Bjorner JB, Kosinski M, Ware JE Jr. Calibration of an item pool for assessing the burden of headaches: an application of item response theory to the headache impact test (HIT). Qual Life Res 2003;12:913-33.
55. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory (HDI). Neurology 1994;44:837-42.
56. Jacobson GP, Ramadan NM, Norris L, Newman CW. Headache disability inventory (HDI): short-term test-retest reliability and spouse perceptions. Headache 1995;35:534-9.
57. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963-74.
58. Ware JE Jr, Sherbourne CD. The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
59. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
60. Holroyd KA. Assessment and psychological management of recurrent headache disorders. J Consult Clin Psychol 2002;70:656-77.
61. Altman DG. Practical statistics for medical research, 1st edn. London: Chapman and Hall, 1991, p. 1-611.
62. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis) uses of baseline data in clinical trials. Lancet 2000;355:1064-9.
63. Anttila P. Tension-type headache in childhood and adolescence. Lancet Neurol 2006;5:268-74.
64. Pearn J. Publication: an ethical imperative. BMJ 1995;310:1313-15.
65. International Headache Society. Ethics Subcommittee. Ethical issues in headache research and management: report and recommendations of the ethics subcommittee of the International Headache Society. Cephalalgia 1998;18:505-29.
66. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.